Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of High-level Oxygen Therapy on the Reconditioning of Type I Hypoxemic Respiratory Insufficiency Patients in Intensive Care

NCT04022603 is registered in ClinicalTrials.gov with Dr David DE BELS as lead sponsor.

NCT NCT04022603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04022603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of High-level Oxygen Therapy on the Reconditioning of Type I Hypoxemic Respiratory Insufficiency Patients in Intensive Care
Lead sponsor
Dr David DE BELS
Phase
Not applicable
Overall status
Completed
Start date
August 18, 2017
Completion date
August 3, 2020
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxemic respiratory failure